Ongini E - Search Results

1

Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices.

Marcoli M, Raiteri L, Bonfanti A, Monopoli A, Ongini E, Raiteri M, Maura G. Marcoli M, et al. Among authors: ongini e. Neuropharmacology. 2003 Aug;45(2):201-10. doi: 10.1016/s0028-3908(03)00156-4. Neuropharmacology. 2003. PMID: 12842126

2

Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.

Marchi M, Raiteri L, Risso F, Vallarino A, Bonfanti A, Monopoli A, Ongini E, Raiteri M. Marchi M, et al. Among authors: ongini e. Br J Pharmacol. 2002 Jun;136(3):434-40. doi: 10.1038/sj.bjp.0704712. Br J Pharmacol. 2002. PMID: 12023946 Free PMC article.

3

Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.

Marcoli M, Bonfanti A, Roccatagliata P, Chiaramonte G, Ongini E, Raiteri M, Maura G. Marcoli M, et al. Among authors: ongini e. Neuropharmacology. 2004 Nov;47(6):884-91. doi: 10.1016/j.neuropharm.2004.06.022. Neuropharmacology. 2004. PMID: 15527822

4

Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.

Lozza G, Conti A, Ongini E, Monopoli A. Lozza G, et al. Among authors: ongini e. Pharmacol Res. 1997 Jan;35(1):57-64. doi: 10.1006/phrs.1996.0120. Pharmacol Res. 1997. PMID: 9149317

5

Selective adenosine A2A receptor antagonists.

Ongini E, Monopoli A, Cacciari B, Baraldi PG. Ongini E, et al. Farmaco. 2001 Jan-Feb;56(1-2):87-90. doi: 10.1016/s0014-827x(01)01024-2. Farmaco. 2001. PMID: 11347973 Review.

6

7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.

Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Monopoli A, Ongini E, Varani K, Borea PA. Baraldi PG, et al. Among authors: ongini e. J Med Chem. 2002 Jan 3;45(1):115-26. doi: 10.1021/jm010924c. J Med Chem. 2002. PMID: 11754583

7

Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.

Monopoli A, Conti A, Dionisotti S, Casati C, Camaioni E, Cristalli G, Ongini E. Monopoli A, et al. Among authors: ongini e. Arzneimittelforschung. 1994 Dec;44(12):1305-12. Arzneimittelforschung. 1994. PMID: 7848348

8

Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.

Conti A, Monopoli A, Gamba M, Borea PA, Ongini E. Conti A, et al. Among authors: ongini e. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jul;348(1):108-12. doi: 10.1007/BF00168545. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8377834

9

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, Dionisotti S. Zocchi C, et al. Among authors: ongini e. J Pharmacol Exp Ther. 1996 Feb;276(2):398-404. J Pharmacol Exp Ther. 1996. PMID: 8632302

10

Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.

Monopoli A, Casati C, Lozza G, Forlani A, Ongini E. Monopoli A, et al. Among authors: ongini e. J Pharmacol Exp Ther. 1998 Apr;285(1):9-15. J Pharmacol Exp Ther. 1998. PMID: 9535988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters